Prevacid 24HR Hits Shelves, Targets Rx-Users And Fed-Up Heartburn Sufferers
This article was originally published in The Tan Sheet
Executive Summary
Novartis supports the Nov. 12 launch of over-the-counter proton pump inhibitor Prevacid 24HR with what the firm calls its "largest OTC product launch campaign to date.
You may also be interested in...
After NDA Investment For OTC Switch, Success Swings On More Spending For Advertising
Switch consultant Susan Levy suggests drug firms temper enthusiasm for Rx-to-OTC switches with considering the costs NDAs generate and the histories of switches that haven’t been successes.
Zegerid Ad Focuses On Science As Competitors Seek Emotional Connection
The first television campaign for Zegerid OTC emphasizes the science behind the heartburn drug's unique dual-ingredient formula
Novartis To Launch Nycomed's PPI Pantoloc Control In 14 European Countries
Novartis will launch the OTC proton pump inhibitor Pantoloc Control (pantoprazole 20 mg) in 14 European countries in the second quarter of 2010 under a co-marketing agreement with the product's originator Nycomed